ESC Premium Access

Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy

Congress Presentation

About the speaker

Associate Professor Borislava Mihaylova

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Increased mortality despite successful multifactorial cardiovascular risk reduction in healthy men. 40-year follow-up of the Helsinki businessmen study intervention trial

Speaker: Professor T. Strandberg (Helsinki, FI)

Thumbnail

Added predictive value of follow-up blood-pressure measurements after alteration of therapy on cardiovascular risk in patients with hypertension

Speaker: Ms N. Jaspers (Utrecht, NL)

Thumbnail

Optimizing outreach strategy to identify individuals at risk for diabetes and/or cardiovascular disease: a study of the Sodertalje municipality in Sweden

Speaker: Doctor B. Shahim (Stockholm, SE)

Thumbnail

Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

Speaker: Professor M. Banach (Lodz, PL)

Thumbnail

Sex hormone-binding globulin, aging, and cardiovascular risk

Speaker: Ms E. Aribas (Rotterdam, NL)

Thumbnail

Access the full session

Controversies in cardiovascular risk assessment and prevention

Speakers: Associate Professor B. Mihaylova, Professor T. Strandberg, Ms N. Jaspers, Doctor B. Shahim, Professor M. Banach...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb